Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > TBP.WT.A

<< Previous

Bullboard Posts

Next >>

Comment by Normandton Jul 12, 2022 4:00pm

130 Views

Post# 34818980

RE:TBP.WT.A

Warrant are expired, that's all. //// Warrant exercise price: 40 cents per share at any time prior to 5 p.m. Toronto time on the date that is 36 months following the closing date of the offering (The expiry date of the warrants is July 12, 2022, in the warrant indenture.)

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment